ホームページ Proteases PSMA

PSMA

PSMA製品

  • All (3)
  • PSMA阻害剤 (1)
  • PSMA抗体(2)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S8670 Vipivotide tetraxetan (PSMA-617) Vipivotide tetraxetan (PSMA-617) is a chemically modified PSMA(prostate-specific membrane antigen) inhibitor with a Ki of 0.37 nM.
Method Protocol, 2025, 8(3)58
Pharmaceutics, 2023, 15(3)850
Pharmaceutics, 2023, 15(3)850
A2617 Rosopatamab (Anti-FOLH1 / PSMA) Rosopatamab (Anti-FOLH1 / PSMA) is a humanised monoclonal antibody targeting PSMA. It can be used in cancer research, particularly in prostate cancer. MW: 144.36.
A2912 Pelgifatamab (Anti-FOLH1 / PSMA) Pelgifatamab (anti-FOLH1 / PSMA) is an immunoglobulin G1-kappa monoclonal antibody targated against FOLH1 (folate hydrolase, prostate-specific membrane antigen, psma). MW: 146.24 KD.
S8670 Vipivotide tetraxetan (PSMA-617) Vipivotide tetraxetan (PSMA-617) is a chemically modified PSMA(prostate-specific membrane antigen) inhibitor with a Ki of 0.37 nM.
Method Protocol, 2025, 8(3)58
Pharmaceutics, 2023, 15(3)850
Pharmaceutics, 2023, 15(3)850
A2617 Rosopatamab (Anti-FOLH1 / PSMA) Rosopatamab (Anti-FOLH1 / PSMA) is a humanised monoclonal antibody targeting PSMA. It can be used in cancer research, particularly in prostate cancer. MW: 144.36.
A2912 Pelgifatamab (Anti-FOLH1 / PSMA) Pelgifatamab (anti-FOLH1 / PSMA) is an immunoglobulin G1-kappa monoclonal antibody targated against FOLH1 (folate hydrolase, prostate-specific membrane antigen, psma). MW: 146.24 KD.
united states